minims oxybuprocaine hydrochloride 0.4% w/v eye drops solution
bausch health ireland limited - oxybuprocaine hydrochloride - eye drops, solution - 0.4 percent weight/volume - local anesthetics; oxybuprocaine
minims oxybuprocaine hydrochloride 0.4%w/v
bausch & lomb (nz) ltd - oxybuprocaine hydrochloride 0.4%{relative} - eye drops, solution - 0.4% w/v - active: oxybuprocaine hydrochloride 0.4%{relative} excipient: hydrochloric acid purified water
megapen - strep injection
franklin pharmaceuticals ltd. - procaine benzyl penicillin (lecithin coated), dihydrostreptomycin sulfate - suspension for injection - 20/20 - combinations of antibacterials - bovine - antibacterial
dufa-penstrep 200 mg/ 200 mg per ml suspension for injection (im/sc)
vethealth corporation - procaine benzylpenicillin , dihydrostreptomycin (vet.) - suspension for injection (im/sc) - 200 mg/ 200 mg per ml
procaine benzylpenicillin + dihydrostreptomycin (as sulfate) (vet.) 200,000 iu/250mg per ml suspension for injection (im)
vet specialists, inc.; distributor: vet specialists, inc. - peni-dhs 20,25 - suspension for injection (im) - 200,000 iu/250mg per ml
ancopen 20/20 200mg/200mg per ml suspension for injection (im/sc)
vet specialists, inc.; distributor: vet specialists, inc. - procaine benzylpenicillin , dihydrostreptomycin ( as sulphate) (vet.) - suspension for injection (im/sc) - 200mg/200mg per ml
procaine penicillin
norbrook laboratories australia pty limited - procaine penicillin - unknown - procaine penicillin antibiotic-penicillin active 0.0 - active constituent
procaine penicillin
abbey laboratories pty ltd - procaine penicillin - unknown - procaine penicillin antibiotic-penicillin active 0.0 - active constituent
cilicaine syringe 1.5 procaine benzylpenicillin (procaine penicillin) 1.5g injection syringe
viatris pty ltd - procaine benzylpenicillin, quantity: 1.5 g - injection, suspension - excipient ingredients: sodium citrate dihydrate; water for injections; polysorbate 80 - indications as at 18 february 2002: treatment of moderately severe infections due to penicillin sensitive organisms. therapy should be guided by bacteriological studies, including sensitivity tests and also by clinical response. infections which usually respond to adequate dosage are: group a streptococcal infections including upper respiratory tract infections, skin and skin structure infections and scarlet fever; pneumococcal infections of the respiratory tract; susceptible staphylococcal infections, most gonococcal infections, syphilis, fusospirochaetosis (vincent's gingivitis and pharyngitis). cilicaine syringe 1.5 must be administered by the intramuscular route only (see section 4.2 dose and method of administration).
penbex 200iu/ml+250mg/ml+0,5mg/ml+8mg/ml+15mg/ml suspension for injection
invesa industrial veterinaria - penicillin g procaine, dihydrostreptomycin sulfate, betamethasone, chlorphenamine maleate, procaine hydrochloride - suspension for injection - 200iu/ml+250mg/ml+0,5mg/ml+8mg/ml+15mg/ml